A Third Person Has Received a Transplant of a Genetically Engineered Pig Kidney
A 53-year-old woman was the third to undergo the transplant procedure. Researchers are hoping to monitor the long-term effects.
Combining AI and Crispr Will Be Transformational
The genome-editing technology can be supercharged by artificial intelligence—and the results are already being felt.
Neuralink Plans to Test Whether Its Brain Implant Can Control a Robotic Arm
Elon Musk’s brain implant company is launching a new study to test whether its wireless device can control a robotic arm.
The First Crispr Treatment Is Making Its Way to Patients
It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder. It’s finally being infused into patients.
Bone Marrow Donors Can Be Hard to Find. One Company Is Turning to Cadavers
San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors’ bone marrow in recent months.
RFK Jr. Wants to Reshape US Health Policy. Good Luck With That
Robert F. Kennedy Jr. says he’ll make big changes in the US government if Donald Trump is elected. He may find them hard to pull off, no matter what position he’s appointed to.
A Neuralink Rival Says Its Eye Implant Restored Vision in Blind People
Science Corporation's retinal implant allowed some people who lost their central vision to read, play cards, and recognize faces.
Eight Scientists, a Billion Dollars, and the Moonshot Agency Trying to Make Britain Great Again
The Advanced Research and Invention Agency—ARIA—is the UK's answer to Darpa. But can it put the country back on the scientific map?
An Ultrathin Graphene Brain Implant Was Just Tested in a Person
A Spanish biotech company sees the carbon material as a way to power the brain-computer interfaces of the future.
This Personalized Crispr Therapy Is Designed to Attack Tumors
In a small study, researchers modified patients’ immune cells to target their particular cancer—but it only worked for a third of volunteers.